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ABSTRACT HighlypathogenicavianinﬂuenzaA(HPAI)virusesoftheH5N1subtypehaverecentlyemergedfromavianzoonotic
reservoirstocausefatalhumandisease.AdaptationofHPAIvirusRNA-dependentRNApolymerase(PB1,PB2,andPApro-
teins)andnucleoprotein(NP)tointeractionswithmammalianhostproteinsisthoughttocontributetotheefﬁciencyofviral
RNAsynthesisandtodiseaseseverity.Whileproteomicsexperimentshaveidentiﬁedanumberofhumanproteinsthatassociate
withH1N1polymerasesand/orviralribonucleoprotein(vRNP),howthesehostinteractionsmightregulateinﬂuenzaviruspoly-
merasefunctionsandhostadaptationhasbeenlargelyunexplored.Wetookafunctionalgenomics(RNAinterference[RNAi])
approachtoassesstherolesofanetworkofhumanproteinsinteractingwithinﬂuenzaviruspolymeraseproteinsinviralpoly-
meraseactivityfromprototypeH1N1andH5N1viruses.Amajority(18of31)ofthecellularproteinstested,includingRNA-
binding(DDX17,DDX5,NPM1,andhnRNPM),stress(PARP1,DDB1,andKu70/86),andintracellulartransportproteins,were
requiredforefﬁcientactivityofbothH1N1andH5N1polymerases.NXP2andNF90antagonizedbothpolymerases,andsix
moreRNA-associatedproteinsexhibitedstrain-speciﬁcphenotypes.Remarkably,12proteinsdifferentiallyregulatedH5N1
polymeraseaccordingtoPB2genotypeatmammalian-adaptiveresidue627.Amongthese,DEADboxRNAhelicaseDDX17/p72
facilitatedefﬁcienthuman-adapted(627K)H5N1virusmRNAandviralRNA(vRNA)synthesisinhumancells.Likewise,the
chickenDDX17homologuewasrequiredforefﬁcientavian(627E)H5N1infectioninchickenDF-1ﬁbroblasts,suggestingthat
thisconservedvirus-hostinteractioncontributestoPB2-dependenthostspeciesspeciﬁcityofinﬂuenzavirusandultimatelyto
theoutcomeofhumanHPAIinfections.
IMPORTANCE HighlypathogenicavianinﬂuenzaA(HPAI)viruseshaverecentlyemergedfromwildanddomesticbirdstocause
fatalhumandisease.Inhumanpatients,itisthoughtthatadaptationoftheviralpolymerase,acomplexofviralproteinsrespon-
sibleforviralgeneexpressionandRNAgenomereplication,tointeractionswithmammalianratherthanavianhostproteins
contributestodiseaseseverity.Inthisstudy,weusedcomputationalanalysisandRNAinterference(RNAi)experimentstoiden-
tifyabiologicalnetworkofhumanproteinsthatregulatesanH5N1HPAIviruspolymerase,incomparisontoamammalian
H1N1virus.Of31proteinstested,18(58%)wererequiredforpolymerasefunctioninbothHPAIandH1N1viruses.Remark-
ably,wealsofoundproteinssuchasDDX17thatgovernedtheHPAIviruspolymerase’sadaptationtohumancells.Thesevirus-
hostinteractionsmaythuscontrolpathogenicityofHPAIvirusinhumansandarepromisingtherapeutictargetsforantiviral
drugsinsevereinﬂuenzainfections.
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I
nﬂuenzaAviruses(Orthomyxoviridae)causeseasonalepidemics
in humans and occasionally lethal global pandemics, such as
those of 1918-1919 (H1N1), 1957 (H2N2), 1968 (H3N2), and
2009 (swine-origin H1N1). Currently, highly pathogenic avian
inﬂuenza A (HPAI) virus strains of the H5N1 subtype circulating
in wild and domestic birds are capable of crossing the species
barrierintohumansandcausingsigniﬁcantpulmonary(1–3)and
systemic (4) disease. Reverse-genetics studies have demonstrated
that the viral polymerase (a heterotrimeric complex consisting of
the PB1, PB2, and PA proteins) and nucleoprotein (NP) contrib-
ute to the pathogenicity of H5N1 HPAI viruses in humans and
other mammals (5–7). Experimental evidence also suggests that
adaptation of polymerase proteins and/or NP to interact with
mammalian rather than avian host proteins contributes to efﬁ-
cient viral mRNA, cRNA, and/or viral RNA (vRNA) genome syn-
thesis (8, 9). For avian viruses, adaptations in PB2 (e.g., E627K,
D701N, and Q591K) allow efﬁcient replication in mammalian
systems (10, 11) and are correlated with disease severity in mam-
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itate H5N1 HPAI virus replication in humans (14).
Inhumans,theinﬂuenzaAviruspolymerase-hostinteractome
consists of more than 50 host cell proteins identiﬁed primarily by
mass spectrometry in protein complexes associated with H1N1
inﬂuenza A virus heterotrimeric polymerase, NP, or a viral ribo-
nucleoprotein (vRNP) comprised of these proteins and a vRNA
template (8, 15–21). Although the direct or indirect nature of
manyofthesehostproteininteractionswithviralpolymerasesub-
units, NP, or viral RNAs requires experimental validation, the
discovery of such a large number of interacting proteins suggests
that the processes of inﬂuenza A virus transcription, replication,
and vRNP import/export are potentially dependent on a wide
spectrumofhostfactorsoverthecourseoftheviruslifecycle.Ina
few cases, notably those of RNA-binding proteins (16, 19, 21, 22)
andmoleculartransporters(8,15,20,23),theimportanceofthese
virus-host interactions to the activity of H1N1 polymerases has
been characterized. However, the importance of the majority of
newlyidentiﬁedfactorsforpolymerasefunctionisunknown,par-
ticularly with respect to H5N1 HPAI. Recent RNA interference
(RNAi) analyses of a large number of human genes regulating the
inﬂuenzaAH1N1viruslifecycleconsiderablyexpandedthelistof
host factors that regulate virus replication (24–27). However,
these high-throughput studies did not speciﬁcally examine host
factorswithrespecttoH1N1orH5N1viralpolymeraseRNAsyn-
thesis (viral gene expression and genome replication) functions.
The present study sought a deeper understanding of inﬂuenza
viruspolymerase-hostinteractionsthatregulatepolymeraseactiv-
ity in human cells. We hypothesized that host factors interacting
with H1N1 polymerase might regulate H1N1 and potentially
H5N1 polymerase functions. Using a functional genomics ap-
proach, we describe a network of human proteins that modulate
the polymerases of inﬂuenza A/WSN/1933 virus, a mammalian
H1N1 strain, and A/Viet Nam/1203/2004 (A/VN/1203/04), an
H5N1 HPAI virus isolated from a fatal human case (6). Given the
importance of the polymerase genotype for HPAI infection in
mammals,wealsosearchedforapolymerase-interactinghostfac-
tor(s) that governs adaptation of H5N1 polymerase to human
cells. We identiﬁed host factors within the network that differen-
tially regulated H5N1 HPAI viral polymerase in human cells de-
pending on the PB2 amino acid 627 genotype, such as DEAD box
RNA helicase 17 (DDX17).
RESULTS
H1N1polymerase-interactinghumanproteinsmodulateH1N1
andH5N1polymeraseactivity.Todiscoverhowinteractinghost
proteins regulate inﬂuenza virus polymerases, we ﬁrst analyzed
the H1N1 inﬂuenza A virus polymerase-host interactome (see
Fig. S1 in the supplemental material). Using biological network
analyses (27), we selected 31 of 54 human factors for RNAi phe-
notype studies (Fig. 1A). These 31 factors formed an intercon-
nected network of proteins (Benjamini-Hochberg estimate of
false discovery probability [PBH]  0.011) encoding functions
knowntoregulateinﬂuenzavirusreplication,includingRNApro-
cessing, transcription and translation, molecular transport, cell
cycle, and cell death (17, 26–28).
We then measured the effects of short interfering RNA
(siRNA) knockdown of each of the 31 host factors on A/WSN/33
(H1N1) and A/VN/1203/04 (H5N1) viral polymerase activity in
human cells using minigenome reporter assays (Fig. 1A). We op-
timized minigenome assays to study host factor requirements for
the polymerase by itself (VPOL-mg assay, including NP; see
Fig. S2 in the supplemental material) and during inﬂuenza virus
infection (infection-mg assay) (29). For each host factor targeted
by siRNA (see Table S1), polymerase activity was expressed as a
ratio to the nontarget (control) siRNA value (Fig. 1B), and phe-
notypicdifferencesweretestedforsigniﬁcance(seeTableS2).Cell
viabilityassaysexcludedonlyKPNA4andIDH2fromsubsequent
analyses (see Fig. S3).
Our data rejected the null hypothesis that most host proteins
identiﬁedintheinterconnectednetworkwerebystanders,perhaps
interacting but not affecting viral polymerase function. Instead,
both A/WSN/33 (H1N1) and A/VN/1203/04 (H5N1) viral poly-
merases depended on a common set (18/31, or 58%) of human
host factors (enhancers) for optimal function in both assays
(Fig.1C).ManyenhancerfactorswereRNAbindingorprocessing
proteins (e.g., DDX17, NPM1, and heterogeneous nuclear ribo-
nucleoprotein M [hnRNPM]), molecular transport or chaperone
proteins(KPNA1,KPNA3,HSP90,HSP70,andRanBP5),orpro-
teins responding to DNA damage or cellular stress (PARP1, the
Ku70/86complex,andDDB1).Onlysimultaneousknockdownof
boththeKu70andKu86subunitsshowedasigniﬁcantphenotype,
suggesting redundant functions for Ku proteins vis-a `-vis the in-
ﬂuenza virus polymerase (Fig. 1D). Viral polymerase activity sig-
niﬁcantly increased when NXP2 or NF90 was targeted by siRNA,
suggesting these host proteins are antagonists, or suppressors, of
both H1N1 and H5N1 polymerases. Eleven more factors dis-
played variability depending on the assay and/or strain (see Dis-
cussion). Hsc71/HSPA8 was required only for optimal polymer-
asefunctionininfectedcells,maybeduetothisprotein’sfunction
in cellular stress (see Fig. S2 in the supplemental material).
A protein network that regulates H1N1 and H5N1 poly-
merases. To provide a more coordinated picture of how H1N1
and H5N1 polymerases are regulated by host factors in human
cells, we mapped RNAi viral polymerase phenotypes onto the in-
terconnected network of host proteins extracted from the H1N1
inﬂuenza A virus polymerase-host interactome (see Fig. S1 in the
supplemental material). This functionally enriched regulatory
networkwasexpandedtoencompassadditionalproteinsreported
toaffectinﬂuenzavirusreplication(Fig.2A):DBTandRPS5(25),
hnRNPU (24), hnRNPF (30), KPNB1 (26), CRM1/XPO1 (31),
the EIF4A complex (24, 32), host RNA polymerase II (28), and
PABPC1(32).Moreover,threeproteinsintheregulatorynetwork
(ARRB1,hnRNPK,andRBM14)thatsharedahighdegreeofcon-
nection (k  3 edges) with H1N1 polymerase interactors also
displayed signiﬁcant polymerase phenotypes (Fig. 2A). This sug-
gests that proximal or “hub-like” interactors may contribute to
polymerase functions and in part could explain the relatively low
overlap in gene hits among global inﬂuenza virus RNAi studies
(33).
Host factors that differentially regulate H5N1 polymerase
accordingtoPB2genotypeatmammalian-adaptiveresidue627.
Wethenexploredthehypothesisthathostfactorsintheregulatory
network could modulate not only functions of H1N1 and H5N1
inﬂuenza virus polymerases but also adaptation of HPAI viruses
to human cells. We examined host factor RNAi phenotypes for
two A/VN/1203/04 (H5N1) polymerases side-by-side: that of the
wild-type (wt), human isolate, with a lysine (K) at position 627 in
PB2,andamutantwithachangetoglutamicacid(E),theconsen-
susresiduefoundinmostavianH5N1isolates(11,34).Avianized
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activity than that of the wt/human isolate (PB2|627K) in human
293T cells but still provided sufﬁcient dynamic range for
VPOL-mg assays (Fig. 2B). In the regulatory network, 13/25
(52%) host factors conserved enhancer phenotypes for both wt/
human isolate and avianized H5N1 polymerases (Fig. 2C). Sur-
prisingly, 12/25 (48%) of factors that had been enhancers for the
wt/human isolate showed no signiﬁcant phenotype, or even an-
tagonist phenotypes, for the avianized H5N1 polymerase. RNA-
binding/processingproteins(P0.004,groupenrichmentscore)
andmoleculartransport/chaperoneproteinshaddifferentialphe-
notypes.
ExogenouscDNAexpressionoffourRNA-bindinghostpro-
teins. To complement siRNA experiments on RNA-binding pro-
teinsintheregulatorynetwork,weoverexpressedcDNAplasmids
encoding human NPM1, DDX17, NF90, and hnRNPA1. As ex-
pected from VPOL-mg optimization experiments (see Fig. S2 in
the supplemental material), increasing NP increased viral poly-
merase activity (Fig. 3). NF90 suppressed, and both DDX17 and
NPM1enhanced,H1N1andwt/humanisolateH5N1polymerase
activityincomparisontoresultswithanemptyDNAvector.Thus,
for mammalian-adapted H1N1 and H5N1 polymerases, overex-
pressionphenotypesforDDX17,NPM1,andNF90weregenerally
consistent with RNAi phenotypes (i.e., opposite to VPOL-mg
phenotypes in Fig. 1B). The exception was hnRNPA1, which
showed disparate phenotypes in cDNA assays. Along with results
ofsiRNAexperiments(Fig.1B),thesedatasuggestthathnRNPA1
may have pleiotropic functional interactions with inﬂuenza virus
polymerase in human cells.
Impact of host factors in H5N1 virus replication. We vali-
dated the phenotypes of eight representative RNA-binding pro-
teinsfromtheregulatorynetworkandtwostress-relatedproteins,
PARP1 and USP10, in H5N1 infection of human lung A549 cells.
As with PARP1, knockdown of hnRNPM, DDX17, DDX5,
DDX3X,andNPM1eachledtoasigniﬁcantreductioninthetiter
of A/VN/1203/04 (H5N1) HALo virus (i.e., virus modiﬁed by re-
moval of the hemagglutinin [HA0] protein’s polybasic cleavage
site) released from A549 cells (Fig. 4A), in concordance with phe-
notypes in both the VPOL-mg and infection-mg assays (Fig. 1B).
KnockdownofNXP2orhnRNPH1allowedamildincreaseinthe
FIG 1 Host factors regulate H1N1 and H5N1 inﬂuenza virus polymerase activity in human cells. (A) Host proteins interacting with inﬂuenza A virus
polymerase, NP, and/or vRNP were analyzed by network bioinformatics. A subset of 31 factors was selected to analyze their roles in H1N1 and H5N1 inﬂuenza
virus polymerase activity. For assays for viral polymerase phenotypes, siRNAs targeting speciﬁc host factor transcripts were transfected into HEK 293T cells or
humanlungA549cells.Fortheviralpolymeraseminigenomeassay(VPOL-mg),afterknockdown,HEK293TcellsweretransfectedwithA/WSN/33(H1N1)or
A/VN/1203/04 (H5N1) nucleoprotein and polymerase expression plasmids in optimized ratios, a vRNA promoter minigenome luciferase reporter, and a
constitutive Renilla internal control. For the inﬂuenza virus infection assay (infection-mg), A549 cells were cotransfected with siRNA, a cRNA promoter
minigenome luciferase reporter, and a Renilla internal control and, after knockdown, infected with inﬂuenza A/WSN/33 (H1N1) or A/VN/1203/04 (H5N1)
HALo virus (MOI  0.5). Viral polymerase activity was assessed and normalized by dual-luciferase assay. (B) Heat map of average A/WSN/33 (H1N1) (WSN)
or A/VN/1203/04 (H5N1) (VN) viral polymerase activity in a ratio to the nontarget siRNA value in VPOL-mg and infection-mg assays for the 31 RNAi targets,
nontarget (nontgt) siRNA, and “no siRNA” controls. Targets were ordered and classiﬁed by averaging data from all four conditions (AVG). *, simultaneous
targeting of both subunits of HSP90 or Ku70/86; n.d., not done. (C) Functional classiﬁcation of phenotypes for the 31 host RNAi targets, reﬂecting composite
data from all four experimental conditions. (D) Ku70/XRCC6 and Ku86/XRCC5 targeted individually or simultaneously (Ku70/86) by siRNA in VPOL-mg
(VPOL)andinfection-mg(IFX)assaysfortheA/WSN/33(H1N1)(WSN)andA/VN/1203/04(H5N1)(VN)strains,withsigniﬁcanceindicatedbyanunpaired,
2-tailed t test.
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geting SFPQ, a protein involved in mRNA processing, resulted in
a more signiﬁcant increase in titers. For PARP1 and four RNA-
binding proteins tested, reduced accumulation of NP in H5N1-
infected A549 cells was observed, consistent with the hypothesis
that these factors are required for optimal polymerase function
(Fig. 4B). In A549 cells with substantial knockdown of PARP1,
NPM1,orDDX17attheproteinlevel,viralnucleoproteinexpres-
sion was still reduced 20 h after H5N1 infection (Fig. 4C). Since
A/VN/1203/04 (H5N1) HALo virus undergoes only one life cycle
FIG2 RegulatorynetworkmodulatingH1N1polymeraseandH5N1polymeraseaccordingtoPB2genotypeataminoacidposition627.(A)Proteininteraction
network comprising inﬂuenza virus polymerase-associated cellular proteins and proximal nodes extracted from the human protein interactome by Ingenuity
pathways analysis (IPA), with signiﬁcance estimated by Benjamini-Hochberg test (PBH). H1N1 and H5N1 polymerase-host RNAi phenotype data from
VPOL-mg (vPOL) and infection-mg (iFX) assays are indicated by color according to this study and published references (lit.; Refs. 16, 22, 24–28, 30–32). Edges
between nodes are reported protein-protein interactions; Untested, phenotypic assay(s) not performed for interactor; Other, connecting protein; dashed links,
indirect association reliant on proteins not shown. Inset table: enriched functions found by IPA and Gene Ontology (GO) analyses. (B) Viral polymerase
minigenome reporter assays with 293T cells for two A/VN/1203/04 (H5N1) viral polymerase PB2 genotypes (627K, wild type/human isolate; 627E, avianized
mutant). Fold induction, ratio to results of mock VPOL-mg assay. (C) Average VPOL-mg activity for PB2 627K and 627E genotypes, expressed as a ratio to the
correspondingnontargetsiRNA(Nontgt)valuefor28principalnetworkhostfactors.Phenotypesareclassiﬁedbysigniﬁcanceestimatedbyanunpaired,2-tailed
ttest(enhancerorsuppressor,Pmax0.15;nosigniﬁcantdifferencefromnontargetcontrol,Pmax0.15).Targetsareorderedbymagnitude/phenotype;yaxis,
log2 scale. The Gene Ontology functional cluster of RNA-binding/processing proteins (P value, group enrichment score) among indicated targets exhibiting
differential phenotypes is shown.
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tein results from reduced viral gene expression and/or ampliﬁca-
tion of viral genomes.
DDX17isrequiredforefﬁcientH5N1mRNAandvRNAsyn-
thesis during infection of human cells. For DDX17 knockdown
in the VPOL-mg assay, the divergence between H5N1 PB2|672E
antagonist and PB2|627K enhancer phenotypes was approxi-
mately6.4-fold(Fig.2B).DDX17thusexhibitedcharacteristicsof
a species speciﬁcity factor for H5N1 HPAI polymerase, so we in-
vestigatedmechanismsbywhichDDX17allowsoptimalviralgene
expression in human cells. Surprisingly, DDX17 interacted with
avianized H5N1 polymerase complexes at least as well as, if not
better than, the wt/human isolate in immunoprecipitation exper-
iments (see Fig. S4 in the supplemental material). When DDX17
was targeted by siRNA in human 293T cells, expression of the NP
and M1 proteins was reduced during A/VN/1203/04 (H5N1)
HALo infection (Fig. 5A). Primer extension analysis showed an
approximately 25% loss in synthesis of both hemagglutinin (HA)
and NP vRNA segments and a 30% loss in HA mRNA synthesis,
whenDDX17wastargetedbysiRNA(Fig.5B).ThedecreaseinNP
mRNAwasnotsigniﬁcantatthistimepoint(12hp.i.).Thesedata
indicate that DDX17 is required for maximal viral mRNA and
vRNAsynthesisinhumancellsinfectedbyH5N1virus.However,
it is also possible that DDX17 has an additional posttranscrip-
tional role(s) facilitating viral gene expression.
Avian DDX17 is required for optimal H5N1 replication in
avian cells. While human DDX17 was required for optimal repli-
cation of the wt/human isolate H5N1 virus in human cells, we
asked whether this host factor is required for optimal replication
ofavianizedH5N1virusinaviancells.Thedomesticchicken(Gal-
lusgallus)hasemergedasahostforH5N1HPAIviruses(1).After
identifyingaDDX17orthologinthechickengenomebysequence
comparison,wesynthesizedsiRNAsspeciﬁcallytargetingthechk-
DDX17 transcript (see Table S1 in the supplemental material).
KnockdownofthechkDDX17proteininchickenDF-1ﬁbroblasts
(Fig. 6A) resulted in a 3-fold-decreased viral titer (Fig. 6B) and
signiﬁcantly less NP expression (Fig. 6C) during A/Viet Nam/
1203/04 (H5N1) HALo (PB2|627E) infection. The wild-type/hu-
man isolate (PB2|627K) virus showed a 2-fold decrease in viral
titer (data not shown). Thus, a DDX17-like protein in chicken
cells is required for optimal avian (PB2|627E) H5N1 virus repli-
cation.
DDX17 and NPM1 colocalize with H5N1 NP in the cyto-
plasm late in infection. Finally, we studied the subcellular inter-
actionofDDX17andNPM1withviralNPduringtheH5N1virus
life cycle in human cells. According to the current understanding
of viral ribonucleoprotein (vRNP) export and virion assembly
(31, 35, 36), NP ﬁrst accumulates in the nucleoplasm as a viral
protein, and RNA syntheses progress. An unidentiﬁed signal in-
ducesNPtorelocalizeinsidethenuclearperipheryforsubsequent
export with viral RNA, mediated by NS2/NEP, to the cytoplasm
for microtubule-mediated transport to the plasma membrane,
where new virions bud. In uninfected, interphase HeLa cells, en-
dogenous DDX17 exhibited a punctate, predominantly intranu-
cleardistributionthatwasalteredbymitosis;NPM1,anabundant
RNA chaperone, was mostly cytoplasmic but also was present in
the nucleoli and nucleoplasm (see Fig. S5 in the supplemental
material). Early in the spatial context of H5N1 infection, NPM1
did not overlap with nuclear NP (Fig. 7A). However, by 12 h p.i.,
NPM1 closely associated with NP in the nuclear periphery and
perinuclear region and in discrete punctae in the cytoplasm
(Fig.7B).DDX17initiallyassociatedwithNPinthenucleusandat
micropunctae in the cytoplasm (Fig. 7A) and showed extensive
colocalizationwithNPinthecytoplasmby12hp.i.(Fig.7C).The
relocalization of NPM1 and DDX17 in infected cells contrasted
with the nuclear localization of another enhancer, PARP1
(Fig. 7A). These results suggested that both DDX17 and NPM1
associatewithvRNPthathavebeenexportedtothecytoplasmlate
in the viral life cycle.
DISCUSSION
Host protein regulation of inﬂuenza virus polymerases. Virus-
host interactions modulating the inﬂuenza A virus polymerase
havethepotentialtogovernthereplicationandspeciesspeciﬁcity
of emerging HPAI virus strains. We found that a majority (58%)
of the virus-host interactions explored herein positively regulated
(enhanced) activities of both A/WSN/33 (H1N1) and A/VN/
1203/04(H5N1)polymerases(Fig.1C).Signiﬁcantphenotypesin
theVPOL-mgassay(Fig.1B;seealsoTableS2inthesupplemental
material) suggested that many human host factors can directly
regulateviralpolymeraseactivityintheabsenceofotherviralpro-
teins or cellular pathways induced by infection. Though precise
mechanisms remain to be resolved, one can hypothesize that by
interacting with the enhancer proteins in the regulatory network
(Fig. 2A), inﬂuenza virus polymerases interact with enriched cel-
lular processes (e.g., RNA processing; see Table S3) to achieve a
high level of intranuclear RNA synthesis. Conversely, antagonist
proteins could activate antiviral or RNA stress pathways that in-
hibitpolymerasefunctions,viralproteinexpression,orRNAtraf-
ﬁc. Molecular transport and RNA-related cellular functions were
also identiﬁed by functional genomics (RNAi) surveys (24–27,
33), suggesting the critical nature of these processes, at least for
H1N1 virus infection.
RNA-associatedcellularproteinshavebeenfoundtopositively
or negatively affect viral RNA syntheses (16, 19, 21, 22). Indeed,
FIG 3 Exogenous expression of host factor cDNA modulates inﬂuenza virus
polymerase activity. Subconﬂuent 293T cells were transfected with a vRNA
promoter luciferase minigenome, a constitutively active Renilla luciferase,
cDNA expression plasmids encoding indicated host factors, or empty vector,
andA/WSN/33(WSN)orA/VN/1203/04(H5N1)(VN)witheitherPB2627K
(PB2K,wt/humanisolate)or627E(PB2E,avianizedmutant)polymeraseplas-
mid.Viralpolymeraseactivitywasassessedasaratioofnormalizedpolymerase
activitiestotheemptyvectorvalue,withsigniﬁcanceestimatedbyanunpaired,
2-tailed t test. ns, not signiﬁcant.
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nuclear ribonucleoproteins (hnRNPs) and DEAD box (DDX)
RNA helicases, regulated both H1N1 and H5N1 polymerases
(Fig. 2A and 3) and H5N1 infection in a human lung cell line
(Fig. 4). NF90 (DRBP76/ILF3), an antiviral RNA-binding pro-
tein that restricts H1N1 and H5N1 NP from interacting with
vRNA (22), antagonized polymerase (Fig. 1B and 3). Six RNA-
associated proteins (EBP1 [16], hnRNPK
[25], hnRNPH1, hnRNPA1, RBM14, and
DDX3X) and ARRB1 (25), a signaling
modulator, displayed signiﬁcantly differ-
ential phenotypes between H1N1 and
H5N1 viruses (Fig. 2A). The possibility
that H1N1 and H5N1 viruses differ in
functional adaptation to an RNA-related
process (see Table S3 in the supplemental
material)highlightstheimportanceofex-
ploringstraindifferencesinantiviraldrug
development.
Host factors regulate adaptation of
an HPAI virus polymerase to human
cells. For an H5N1 HPAI virus, wild-
type/human isolate (PB2|627K) and avi-
anized (PB2|627E) polymerases differed
considerably in their reliance on host fac-
tors in the regulatory network (Fig. 2B).
Evidence has suggested that HPAI poly-
merases containing a mammal-adapted
genotype at adaptive residues (e.g., PB2
591,627,and701)areabletointeractwith
a host factor(s) to facilitate efﬁcient RNA
synthesis activity (11, 37). Host factors
thatexhibitedadifferentialphenotypefor
avianized polymerase (Fig. 2B) included
chaperone/transport proteins, consistent
withmodelssuggestedintheliterature(8,
38), and RNA-binding proteins, such as
DDX17. This suggests that an RNA-
relatedprocessmayalsocontributetothe
mechanistic basis of phenotypes related
to the PB2 residue 627 genotype.
DDX17, a protein critical for H5N1
polymerase adaptation to human cells.
DDX17 (p72) and a related protein,
DDX5 (p68), are abundant nuclear ATP-
dependentDEAD-boxRNAhelicasesthat
can heterodimerize (39) and catalyze
RNAunwindingandrearrangement(40).
DDX17 and DDX5 have been implicated
in ribosomal biogenesis (41). Human
DDX17 and DDX5 exhibited consistent,
strong enhancer phenotypes in polymer-
aseassays(Fig.1B)thatwereconﬁrmedin
H5N1 infection, independently of mini-
genome reporters. DDX17 and DDX5
were required for A/VN/1203/04 (H5N1)
wt/human isolate (PB2|627K) but not
avianizedmutant(PB2|627E)polymerase
activity (Fig. 2B). When overexpressed in
humancells,DDX17alsoenhancedactiv-
ity of wt/human isolate but not avianized H5N1 polymerase
(Fig. 3). Mechanistically, human DDX17 facilitated both mRNA
and vRNA synthesis during wt/human isolate H5N1 infection
(Fig. 5B). DDX17 closely colocalized with NP in the cell nucleus
early (3 h p.i.) in H5N1 infection (Fig. 7A), consistent with a role
in viral RNA synthesis.
Proteomics and immunoprecipitation experiments have
FIG 4 Host factor RNAi silencing alters progression of the H5N1 virus life cycle. (A) Average relative
titers of virus released 20 h p.i. from A549 cells targeted 36 h prior by siRNA transfection and infected
byinﬂuenzaA/VN/1203/04(H5N1)HALovirus(MOI0.1).Valuesshownareaveragesofplaqueand
limiting dilution assay ratios for each host target siRNA relative to nontarget (nontgt) siRNA values,
with signiﬁcance estimated by an unpaired, 2-tailed t test. (B) Viral nucleoprotein (NP) expression in
A549 cells mock-treated or transfected with nontarget (Nontgt) or siRNA-targeting selected host fac-
tors 24 h prior to infection with A/VN/1203/04 (H5N1) HALo virus (MOI  2). Cultures were ﬁxed 6
hp.i.forIFAwithmonoclonalanti-NPandAlexa-555-labeledsecondaryantibodyand4=,6-diamidino-
2-phenylindole (DAPI) nuclear staining (i). Fluorescence intensity quantiﬁcation of Alexa-555 in rep-
resentativeimagesasaratiotothenontargetsiRNAvalue(ii).(C)NPexpression(20hp.i.)inA549cells
infected with A/VN/1203/04 (H5N1) HALo (MOI  0.5). Infected cell lysates were separated by SDS-
PAGE and immunoblotted, and separated strips were probed with anti-NP or anti-glyceraldehyde-3-
phosphatedehydrogenase(GAPDH)antibodies.DensitometrydepictingtheratioofNPtoGAPDHfor
equal protein samples is indicated (i). A549 cells transfected with siRNA (Non, nontarget; P1 and P2
indicate two different siRNAs, while P12 indicates both pooled, targeting PARP1; DDX17, siRNA pool
targeting DDX17; NPM1, siRNA pool targeting nucleophosmin) were lysed and run on an SDS-PAGE
gel, and Western blots were probed with antibodies as indicated (ii).
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shown)associatewithWSN(H1N1)polymerase.Surprisingly,we
found that DDX17 also associated with either wt/human isolate
(PB2|627K) or avianized (PB2|627E) HPAI (H5N1) polymerase
complexes and with either PB2 alone (see Fig. S5 in the supple-
mental material). However, the presence of another enhancer,
NPM1,wasgreaterinthewt/humanisolatePB2complexes.Thus,
the failure of avian H5N1 polymerase to take advantage of
DDX17’s ability to facilitate viral RNA synthesis is apparently not
due simply to an inability of human DDX17 to interact with a
heterotrimeric polymerase containing PB2|627E but perhaps in-
volves association with another protein(s), such as NPM1 or
DDX5. We also found that while the chicken DDX17 homologue
wasrequiredforH5N1proteinexpression(Fig.6C)andviralrep-
lication(Fig.6B),humanDDX17antagonizedavianizedpolymer-
ase in human cells (Fig. 2B). Thus, physical association of
PB2|627E with avian DDX17 in avian cells might mechanistically
enhance replication, while in contrast, interaction with human
DDX17 could inhibit unadapted HPAI virus polymerase in hu-
man cells. This hypothesis might explain why avian inﬂuenza vi-
rus polymerases are blocked from efﬁcient RNA synthesis in hu-
man cells by an antagonistic host factor(s) (42). Taken together,
H5N1 virus requires a DDX17-like protein in both avian and hu-
man cells, suggesting conservation of a polymerase-host interac-
tion critical for H5N1 survival in different host species.
Possible roles for RNA chaperones in vRNP export from the
nucleus. We found that two RNA-associated proteins (DDX17
andNPM1)mayhaveadditionalfunctionsduringinﬂuenzavirus
vRNPexportfromthenucleus.NuclearexportofvRNPoccursin
a CRM1-dependent manner (31). DDX17 and DDX5 function
together in ribosomal pre-rRNA processing, and rRNA is also
exported from the nucleus in a CRM1-dependent manner (41,
43). Meanwhile, the ribosomal protein RPL5, which associates
withinﬂuenzavirusvRNP(18),requiresNPM1fornuclearexport
(44). Late in H5N1 virus infection, DDX17 and NPM1 had redis-
tributed in the cytoplasm in conjunction with NP (Fig. 7), likely
signifyingexportofnascentvRNPfromthenucleus(35).Thus,we
FIG 5 DDX17 facilitates viral RNA synthesis in H5N1 infection of human
cells. (A) 293T cells were targeted by Nontarget (Non) or DDX17 (DX17)
siRNA.After24hofknockdown,cellswereinfectedbyA/VN/1203/04(H5N1)
HALo virus (MOI  1). Cell protein lysates were analyzed 12 h p.i. for the
DDX17,NP,M1,andactinproteinsbyWesternblotting.(B)Primerextension
analysiswithspeciﬁcprimersforHA(i)orNP(ii)mRNAandvRNAsynthesis,
as indicated, for mock-infected control or 293T cells 12 h p.i. with A/VN/
1203/04 (H5N1) HALo virus (MOI  1). 5S, rRNA loading control; *, non-
speciﬁc background band. Graphs show RNA quantiﬁcation by densitometry
normalized to 5S rRNA and background; signiﬁcance was estimated by an
unpaired, 2-tailed t test from density histograms and standard deviations.
FIG 6 DDX17 is required for optimal H5N1 infection in chicken ﬁbroblasts.
(A) Targeted knockdown of chicken DDX17. Nontarget siRNA (Ntgt) or spe-
ciﬁcsiRNAtargetingaGallusgallusDDX17ortholog(DX17)wassynthesized,
puriﬁed, pooled, and transfected into DF-1 cells. After 48 h of knockdown,
cellswerelysedandanalyzedbyWesternblottingforchickenDDX17andactin
withcross-reactive,polyclonalantisera.(B)DecreasedH5N1virusreplication
with knockdown of chicken DDX17. Chicken DF-1 ﬁbroblasts transfected by
nontarget(Nontgt)orchickenDDX17(chkDDX17)siRNAwereinfectedafter
48 h with A/VN/1203/04 (H5N1) HALo (PB2|627E) virus (MOI  0.5). Viral
titers (16 h p.i.) were estimated by limiting dilution relative to the nontarget
siRNAcontrolvalue,andsigniﬁcancewastestedbyanunpaired,2-tailedttest.
(C) DF-1 cells were infected with avianized A/VN/1203/04 (H5N1) HALo
(PB2|627E) virus (MOI  0.5) and ﬁxed 20 h p.i. NP expression in infected
DF-1 cells was analyzed by IFA with monoclonal anti-NP-labeled and Alexa-
555-labeled anti-mouse secondary antibody and DAPI nuclear staining (i),
and ﬂuorescence intensity was quantiﬁed relative to the nontarget siRNA
value, with signiﬁcance tested by an unpaired, 2-tailed t test (ii).
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evolved to hijack aspects of the CRM1-dependent export mecha-
nism of another large ribonucleoprotein complex, the ribosome,
in order to facilitate their own vRNP nuclear export.
Mapping functions in the inﬂuenza virus polymerase-host
interactome. Genomics experiments, from proteomics and
genome-wide RNAi surveys to more targeted studies examining
particularaspectsofviruslifecycles(e.g.,inﬂuenzaviruspolymer-
ase regulation), allow for the ﬁrst time systematic analysis of the
complexityofhost-pathogenregulatorynetworks.Whilethepres-
ent study identiﬁes host factors important for inﬂuenza virus
polymerase function and host species tropism, a comprehensive,
dynamic model of how host interactions regulate inﬂuenza virus
RNA synthesis, gene expression, and genome replication is far
from complete. Adoption of common standards for RNAi data
submission(45)wouldallowformoreaccuratemeta-analysisand
integration of multiple genomics data types to model complex
virus-host interactions (27). We have demonstrated that func-
tional genomics analysis of host proteins provides a novel means
to study the phenotypes of inﬂuenza virus polymerase mutants
and to map adaptation of emerging H5N1 HPAI polymerases to
human cells. This approach has the potential to identify novel
targetsfortherapeuticinterventioninsevereinﬂuenzavirusinfec-
tions.
MATERIALS AND METHODS
Viruses. Attenuated inﬂuenza A/Viet Nam/1203/2004 (H5N1) HALo vi-
ruses (PB2|627K and PB2|627E) were generated by reverse genetics as
described previously (13, 46), with removal of the hemagglutinin (HA0)
protein’s polybasic cleavage site (GenBank accession no. CY077101); the
virusundergoesonlyoneroundofreplicationintheabsenceofexogenous
trypsin.Allotherwild-typeviralgenesegmentswereunmodiﬁed.Titersof
H5N1 inﬂuenza viruses were determined by plaque assay on MDCK cells
(46)orbylimiting-dilutionassaysonA549orchickenDF-1cells.Titersof
A/WSN/33 (H1N1) virus were determined as described previously (18,
26).
Bioinformatics analyses. The H1N1 polymerase-host interactome
wasinitiallyanalyzedusingIngenuitypathwaysanalysis(IPA7.6;Ingenu-
itySystems,Redwood,CA).Thetop-scoring,interconnectedsubnetwork
wasextracted,expandedbyliteraturecuration,andtestedforsigniﬁcance
by a Benjamini-Hochberg (PBH) estimate for false discovery probability,
i.e.,theprobabilitythatthelinkagesandfunctionsassignedtothederived
node-edge sets are due to chance alone. The DAVID software program
(47) analyzed Gene Ontology (GO) term enrichment and functional
group clustering.
Targeting host genes with siRNA. Nontarget (scrambled) siRNA or
siRNAtargetingspeciﬁchumanorchickentranscripts(seeTableS1inthe
supplemental material) was transfected into 293T, A549, or DF-1 cells at
10 to 15 nM. For a subset of siRNA, efﬁcacy of RNAi knockdown was
evaluated by Western blotting, reverse transcription-PCR (RT-PCR), or
siRNAtargetinggreenﬂuorescentprotein(GFP)(seeFig.S2).Cellviabil-
ity (see Fig. S3) was measured by a Renilla reporter, CellTiter-Glo, and
caspase-Glo 3/7 assays (Promega Corp., Madison, WI).
Minigenome reporter assays. The VPOL-mg (vRNA-luciferase re-
porter)assaywithHEK293Tcells(18)wasoptimizedwithplasmidratios
of 10:2:1:2 (NP/PB1/PB2/PA) to assay autonomous polymerase function
(see Fig. S2 in the supplemental material). For cDNA experiments, ratios
were5:2:1:2.VPOL-mgandsiRNAconditionsweretestedfortwoknown
polymerase interactors, PARP1 (18) and RanBP5 (15) (see Fig. S2). The
infection-mg (cRNA-luciferase reporter) assay (29) was adopted to mea-
sure polymerase function in infected A549 cells. In minigenome reporter
assays,reportergeneexpression(“viralpolymeraseactivity”)isdependent
on viral polymerase-mediated transcription and replication of a model
inﬂuenza virus RNA, measured by a Dual-Luciferase reporter assay (Pro-
mega Corporation, Madison, WI). Signiﬁcance of differences relative to
nontargetsiRNAwereestimatedbyanunpaired,2-tailedttesttocalculate
P values, with a Pmax value of 0.15 regarded as no signiﬁcant difference
(see Table S2). Data for each RNAi target will be available in PubChem
underMinimumInformationAboutanRNAiExperiment(MIARE)data
standards (45).
FIG7 Colocalization of H5N1 NP with DDX17 and NPM1 during infection.
(A) IFA of HeLa cells infected with inﬂuenza A/VN/1203/04 (H5N1) HALo
virus(MOI0.5)wereﬁxed3hp.i.andincubatedwithanti-NPmonoclonal
andanti-NPM1or-DDX17polyclonalantibodiesoranti-PARP1monoclonal
and anti-NP polyclonal antibodies, Alexa-555-labeled (red) or Alexa-488-
labeled (green) secondary antibodies, and DAPI nuclear stain (blue). Images
were captured by structured illumination, providing deﬁned submicron ver-
tical (z-plane) optical sections imaged through the cell, and merged as indi-
cated. (B) IFA of HeLa cells infected with A/VN/1203/04 (H5N1) HALo virus
(MOI  0.2) ﬁxed 12 h p.i. Colocalization (yellow) of NP and NPM1 in the
nuclearperipheryandperinuclearregion(openarrowhead),indiscretepunc-
tae in the cytoplasm (arrows), or in proximity to the plasma membrane (ﬁlled
arrowhead) is indicated. (C) IFA of HeLa cells infected with A/VN/1203/04
(H5N1) HALo virus (MOI  0.2) ﬁxed at 3 h p.i. or 12 h p.i. Colocalization
(yellow) of NP and DDX17 in the nucleus (open arrowhead) or in discrete
punctae in the cytoplasm (arrows) is indicated. Structured illuminations of
horizontal optical sections (xy plane) were stacked to reconstruct lateral (z-
plane) images of infected cells.
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munoﬂuorescence assay (IFA) and probed with speciﬁc primary anti-
bodies(describedinTextS1[MaterialsandMethods]inthesupplemental
material) and Alexa Fluor-linked (488-nm anti-rabbit and 555-nm anti-
mouse) IgG secondary antibodies (Molecular Probes, Eugene, OR). For
subcellular localization studies, HeLa cells were infected with A/VN/
1203/04(H5N1)HALovirus(multiplicityofinfection[MOI]of0.5),and
imaged by structured illumination on an Axioplan 2 microscope (Zeiss,
Göttingen,Germany)providingoptical,submicronvertical(z-plane)sec-
tions through the cell.
Molecularbiologyassays.Primerextensionassayswereperformedas
described(23),using 32P-labeledDNAoligonucleotidestoA/VN/1203/04
HA and NP, detecting vRNA segments and mRNA, and a 5S rRNA load-
ing control. Immunoblot and immunoprecipitation assays were per-
formed as described previously (18), with speciﬁc protocols described in
Text S1 in the supplemental material (supplemental Materials and Meth-
ods).
Refer to Text S1 (supplemental Materials and Methods) for detailed
descriptions of all methods and reagents.
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